Protara Therapeutics (TARA) Competitors $3.05 -0.07 (-2.24%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$3.12 +0.07 (+2.30%) As of 07/11/2025 07:41 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock TARA vs. MBX, RZLT, RGNX, TRML, SVRA, ERAS, TECX, ETON, ITOS, and VIGLShould you be buying Protara Therapeutics stock or one of its competitors? The main competitors of Protara Therapeutics include MBX Biosciences (MBX), Rezolute (RZLT), REGENXBIO (RGNX), Tourmaline Bio (TRML), Savara (SVRA), Erasca (ERAS), Tectonic Therapeutic (TECX), Eton Pharmaceuticals (ETON), iTeos Therapeutics (ITOS), and Vigil Neuroscience (VIGL). These companies are all part of the "pharmaceutical products" industry. Protara Therapeutics vs. Its Competitors MBX Biosciences Rezolute REGENXBIO Tourmaline Bio Savara Erasca Tectonic Therapeutic Eton Pharmaceuticals iTeos Therapeutics Vigil Neuroscience MBX Biosciences (NYSE:MBX) and Protara Therapeutics (NASDAQ:TARA) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, profitability, institutional ownership, earnings, valuation, media sentiment, dividends and analyst recommendations. Which has stronger valuation & earnings, MBX or TARA? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMBX BiosciencesN/AN/AN/AN/AN/AProtara TherapeuticsN/AN/A-$44.60M-$1.72-1.77 Does the media refer more to MBX or TARA? In the previous week, Protara Therapeutics had 1 more articles in the media than MBX Biosciences. MarketBeat recorded 1 mentions for Protara Therapeutics and 0 mentions for MBX Biosciences. Protara Therapeutics' average media sentiment score of 1.87 beat MBX Biosciences' score of 0.00 indicating that Protara Therapeutics is being referred to more favorably in the news media. Company Overall Sentiment MBX Biosciences Neutral Protara Therapeutics Very Positive Do insiders and institutionals hold more shares of MBX or TARA? 38.1% of Protara Therapeutics shares are owned by institutional investors. 52.2% of MBX Biosciences shares are owned by insiders. Comparatively, 8.4% of Protara Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Is MBX or TARA more profitable? MBX Biosciences' return on equity of 0.00% beat Protara Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets MBX BiosciencesN/A N/A N/A Protara Therapeutics N/A -36.37%-33.29% Do analysts prefer MBX or TARA? MBX Biosciences currently has a consensus target price of $37.50, suggesting a potential upside of 187.58%. Protara Therapeutics has a consensus target price of $20.50, suggesting a potential upside of 572.13%. Given Protara Therapeutics' stronger consensus rating and higher possible upside, analysts clearly believe Protara Therapeutics is more favorable than MBX Biosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score MBX Biosciences 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 3.00Protara Therapeutics 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 3.14 SummaryProtara Therapeutics beats MBX Biosciences on 6 of the 9 factors compared between the two stocks. Get Protara Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for TARA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TARA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TARA vs. The Competition Export to ExcelMetricProtara TherapeuticsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$117.68M$2.42B$5.56B$9.11BDividend YieldN/A1.79%5.06%4.01%P/E Ratio-1.779.4228.2620.26Price / SalesN/A732.10437.10166.10Price / CashN/A164.4637.1257.67Price / Book0.644.608.045.49Net Income-$44.60M$31.26M$3.19B$250.45M7 Day Performance4.96%4.80%3.62%4.79%1 Month Performance-2.87%8.17%5.98%9.59%1 Year Performance29.24%-3.88%29.39%16.41% Protara Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TARAProtara Therapeutics1.9258 of 5 stars$3.05-2.2%$20.50+572.1%+29.2%$117.68MN/A-1.7730MBXMBX Biosciences1.7076 of 5 stars$12.88+3.3%$37.50+191.1%N/A$430.50MN/A0.0036Positive NewsRZLTRezolute2.5764 of 5 stars$4.98+3.3%$11.83+137.6%+11.9%$425.89MN/A-4.3340News CoverageHigh Trading VolumeRGNXREGENXBIO4.0438 of 5 stars$8.43-3.5%$31.63+275.1%-32.0%$422.85M$83.33M-2.71370News CoverageTRMLTourmaline Bio2.0576 of 5 stars$15.96-2.8%$49.33+209.1%+20.6%$409.85MN/A-4.9744Positive NewsSVRASavara2.15 of 5 stars$2.34+6.8%$5.60+139.3%-51.1%$404.45MN/A-4.8720Positive NewsHigh Trading VolumeERASErasca3.3566 of 5 stars$1.42-1.4%$4.57+221.9%-51.2%$402.27MN/A-2.29120News CoverageTECXTectonic Therapeutic2.6236 of 5 stars$20.78-2.6%$83.60+302.3%+33.6%$388.03MN/A-2.84120Gap DownETONEton Pharmaceuticals1.9755 of 5 stars$14.39-0.4%$29.67+106.2%+324.9%$385.94M$39.01M-79.9420Gap UpITOSiTeos Therapeutics3.3148 of 5 stars$10.07-1.1%$15.86+57.5%-36.3%$385.38M$35M-3.3190VIGLVigil Neuroscience3.7612 of 5 stars$7.99flat$10.80+35.2%+85.1%$381.04MN/A-3.9040News Coverage Related Companies and Tools Related Companies MBX Alternatives RZLT Alternatives RGNX Alternatives TRML Alternatives SVRA Alternatives ERAS Alternatives TECX Alternatives ETON Alternatives ITOS Alternatives VIGL Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TARA) was last updated on 7/13/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Protara Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Protara Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TARA Stock Alerts